Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline test.
A defect in the level of monoamine oxidase activity of platelets was observed in essential arterial hypertension. This defect seems dependent upon a lower rate of synthesis of the enzyme and not to the presence of an isoenzyme, as the net rate of return of the enzymatic activity after pargyline inhibition does not significantly differ between hypertensive and normotensive subjects.
D000328:Adult; D001792:Blood Platelets / Q000201:enzymology; D005260:Female; D006207:Half-Life; D006801:Humans; D006973:Hypertension / Q000201:enzymology*; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D010293:Pargyline; D011506:Proteins / Q000378:metabolism; D013997:Time Factors
D011506:Proteins; D010293:Pargyline; D008995:Monoamine Oxidase